Dr Adam Walker

STAFF PROFILE

Position

Research Fellow, Trisno Family

Faculty

Faculty of Health

Department

School of Medicine

Campus

HERB

Publications

Filter by

2021

Increasing Nrf2 activity as a treatment approach in neuropsychiatry

G Morris, A Walker, K Walder, M Berk, W Marx, A Carvalho, M Maes, B Puri

(2021), pp. 1-25, Molecular neurobiology, Heidelberg, Germany, C1

journal article

The Effect of Adjunctive Mangosteen Pericarp on Cognition in People With Schizophrenia: Secondary Analysis of a Randomized Controlled Trial

Wolfgang Marx, David Skvarc, Mohammadreza Mohebbi, Adam Walker, Alcy Meehan, Alyna Turner, Andrea Baker, Seetal Dodd, Sue Cotton, James Scott, Bianca Kavanagh, Melanie Ashton, Ellie Brown, John McGrath, Michael Berk, Olivia Dean

(2021), Vol. 12, pp. 1-8, Frontiers in Psychiatry, Lausanne, Switzerland, C1

journal article

Statins: Neurobiological underpinnings and mechanisms in mood disorders

A Walker, Y Kim, I Borissiouk, R Rehder, S Dodd, G Morris, A Nierenberg, M Maes, B Fernandes, O Dean, L Williams, H Eyre, S Kim, S Zoungas, A Carvalho, M Berk

(2021), Vol. 128, pp. 693-708, Neuroscience and Biobehavioral Reviews, Amsterdam, The Netherlands, C1

journal article

Baseline serum amino acid levels predict treatment response to augmentation with N-acetylcysteine (NAC) in a bipolar disorder randomised trial

C Bortolasci, A Turner, M Mohebbi, Z Liu, M Ashton, L Gray, W Marx, A Walker, G Kowalski, F Jacka, M Berk, O Dean, K Walder

(2021), Vol. 142, pp. 376-383, Journal of Psychiatric Research, Amsterdam, The Netherlands, C1

journal article
2020

The impact of removal of ovarian hormones on cholinergic muscarinic receptors: Examining prepulse inhibition and receptor binding

S Ch’ng, A Walker, M McCarthy, T Le, N Thomas, A Gibbons, M Udawela, S Kusljic, B Dean, A Gogos

(2020), Vol. 10, Brain Sciences, Basel, Switzerland, C1

journal article

Minocycline for the treatment of mental health and neurological conditions: study protocol of a systematic review and meta-analysis

C Bortolasci, W Marx, A Walker, K Hasebe, B Kavanagh, M Morris, M Mohebbi, A Turner, L Gray, L Berk, K Walder, M Berk, O Dean

(2020), Vol. 10, pp. 1-4, BMJ open, London, Eng., C1

journal article

Minocycline as adjunctive treatment for major depressive disorder: Pooled data from two randomized controlled trials

R Zazula, M Husain, M Mohebbi, A Walker, I Chaudhry, A Khoso, M Ashton, B Agustini, N Husain, J Deakin, A Young, M Berk, B Kanchanatawan, C Ng, M Maes, L Berk, A Singh, G Malhi, O Dean

(2020), pp. 1-15, Australian and New Zealand Journal of Psychiatry, London, Eng., C1

journal article

The kynurenine pathway in major depressive disorder, bipolar disorder, and schizophrenia: a meta-analysis of 101 studies

W Marx, A McGuinness, T Rocks, A Ruusunen, J Cleminson, A Walker, S Gomes-da-Costa, M Lane, M Sanches, A Diaz, P Tseng, P Lin, M Berk, G Clarke, A O’Neil, F Jacka, B Stubbs, A Carvalho, J Quevedo, J Soares, B Fernandes

(2020), pp. 1-21, Molecular Psychiatry, London, Eng., C1

journal article

Adjunctive Garcinia mangostana Linn. (Mangosteen) pericarp for Schizophrenia: A 24-week double-blind, randomized, placebo controlled efficacy trial Péricarpe d'appoint Garcinia mangostana Linn (mangoustan) pour la schizophrénie : un essai d'efficacité de 24 semaines, à double insu, randomisé et contrôlé par placebo

Alyna Turner, Andrea Baker, Olivia Dean, Adam Walker, Seetal Dodd, Susan Cotton, James Scott, Bianca Kavanagh, Melanie Ashton, Ellie Brown, John McGrath, Michael Berk

(2020), The Canadian Journal of Psychiatry, Thousand Oaks, Calif., C1

journal article
2019

Incidence and characteristics of the nocebo response from meta-analyses of the placebo arms of clinical trials of olanzapine for bipolar disorder

Seetal Dodd, Adam Walker, Alan Brnabic, Nancy Hong, Amber Burns, Michael Berk

(2019), Vol. 21, pp. 142-150, Bipolar disorders, Chichester, Eng., C1

journal article

Insulin-stimulated mTOR activation in peripheral blood mononuclear cells associated with early treatment response to lithium augmentation in rodent model of antidepressant-resistance

A Walker, J Price, K Borreggine, S Sutor, A Gogos, J McGillivray, M Frye, Susannah Tye

(2019), Vol. 9, pp. 1-11, Translational psychiatry, London, Eng., C1

journal article

Statins and inflammation: new therapeutic opportunities in psychiatry

Sung-Wan Kim, Hee-Ju Kang, Min Jhon, Ju-Wan Kim, Ju-Yeon Lee, Adam Walker, Bruno Agustini, Jae-Min Kim, Michael Berk

(2019), Vol. 10, Frontiers in psychiatry, Lausanne, Switzerland, C1

journal article

The therapeutic potential of mangosteen pericarp as an adjunctive therapy for bipolar disorder and schizophrenia

Melanie Ashton, Olivia Dean, Adam Walker, Chiara Bortolasci, Chee Ng, Malcolm Hopwood, Brian Harvey, Marisa Möller, John McGrath, Wolfgang Marx, Alyna Turner, Seetal Dodd, James Scott, Jon-Paul Khoo, Ken Walder, Jerome Sarris, Michael Berk

(2019), Vol. 10, pp. 1-17, Frontiers in psychiatry, Lausanne, Switzerland, C1

journal article

Protocol and rationale: a 24-week double-blind, randomized, placebo controlled trial of the efficacy of adjunctive garcinia mangostanaLinn. (mangosteen) pericarp for schizophrenia

Alyna Turner, John McGrath, Olivia Dean, Seetal Dodd, Andrea Baker, Susan Cotton, James Scott, Bianca Kavanagh, Melanie Ashton, Adam Walker, Ellie Brown, Michael Berk

(2019), Vol. 17, pp. 297-307, Clinical psychopharmacology and neuroscience, Seoul, South Korea, C1

journal article

Has the sun set for seasonal affective disorder and HPA axis studies? A systematic review and future prospects

B Agustini, M Bocharova, A Walker, M Berk, A Young, M Juruena

(2019), Vol. 256, pp. 584-593, Journal of affective disorders, Amsterdam, The Netherlands, C1

journal article

The compensatory antioxidant response system with a focus on neuroprogressive disorders

G Morris, B Puri, A Walker, M Berk, K Walder, C Bortolasci, W Marx, A Carvalho, M Maes

(2019), Vol. 95, Progress in neuro-psychopharmacology and biological psychiatry, Amsterdam, The Netherlands, C1

journal article

Neurobiology and therapeutic potential of cyclooxygenase-2 (COX-2) inhibitors for inflammation in neuropsychiatric disorders

Rickinder Sethi, Nieves Gomez-Coronado, Adam Walker, Oliver Robertson, Bruno Agustini, Michael Berk, Seetal Dodd

(2019), Vol. 10, pp. 1-21, Frontiers in psychiatry, Lausanne, Switzerland, C1

journal article

Myalgic encephalomyelitis/chronic fatigue syndrome: from pathophysiological insights to novel therapeutic opportunities

G Morris, B Puri, A Walker, M Maes, A Carvalho, K Walder, C Mazza, M Berk

(2019), Vol. 148, pp. 1-20, Pharmacological research, Amsterdam, The Netherlands, C1

journal article

Shared pathways for neuroprogression and somatoprogression in neuropsychiatric disorders

G Morris, B Puri, A Walker, M Maes, A Carvalho, C Bortolasci, K Walder, M Berk

(2019), Vol. 107, pp. 862-882, Neuroscience and biobehavioral reviews, Amsterdam, The Netherlands, C1

journal article
2018

Cell death pathways: a novel therapeutic approach for neuroscientists

G Morris, A Walker, M Berk, M Maes, B Puri

(2018), Vol. 55, pp. 5767-5786, Molecular neurobiology, New York, N.Y., C1

journal article

Current and emerging pharmacotherapies for cessation of tobacco smoking

N Gómez-Coronado, A Walker, M Berk, S Dodd

(2018), Vol. 38, pp. 235-258, Pharmacotherapy, Chichester, Eng., C1

journal article

Why should neuroscientists worry about iron? The emerging role of ferroptosis in the pathophysiology of neuroprogressive diseases

G Morris, M Berk, A Carvalho, M Maes, A Walker, B Puri

(2018), Vol. 341, pp. 154-175, Behavioural brain research, Amsterdam, The Netherlands, C1

journal article

Leaky brain in neurological and psychiatric disorders: drivers and consequences

Gerwyn Morris, Brisa Fernandes, Basant Puri, Adam Walker, Andre Carvalho, Michael Berk

(2018), Vol. 52, pp. 924-948, Australian and New Zealand journal of psychiatry, London, Eng., C1

journal article

Differential effects of chronic 17β-estradiol treatment on rat behaviours relevant to depression

Andrea Gogos, Madeleine McCarthy, A Walker, Madhara Udawela, Andrew Gibbons, Brian Dean, Snezana Kusljic

(2018), Vol. 30, pp. 1-10, Journal of neuroendocrinology, Chichester, Eng., C1

journal article
2016

Nucleus accumbens deep-brain stimulation efficacy in ACTH-pretreated rats: alterations in mitochondrial function relate to antidepressant-like effects

Y Kim, S McGee, J Czeczor, A Walker, R Kale, A Kouzani, K Walder, M Berk, S Tye

(2016), Vol. 6, pp. 1-7, Translational psychiatry, London, Eng., C1

journal article

Progesterone: the neglected hormone in schizophrenia? A focus on progesterone-dopamine interactions

Jeehae Sun, Adam Walker, Brian Dean, Maarten van den Buuse, Andrea Gogos

(2016), Vol. 74, pp. 126-140, Psychoneuroendocrinology, Amsterdam, The Netherlands, C1

journal article
2015

Peripheral proinflammatory markers associated with ketamine response in a preclinical model of antidepressant-resistance

A Walker, B Foley, S Sutor, J Mc Gillivray, M Frye, S Tye

(2015), Vol. 293, pp. 198-202, Behavioural brain research, Amsterdam, The Netherlands, C1

journal article
2014

Stress, inflammation, and cellular vulnerability during early stages of affective disorders: Biomarker strategies and opportunities for prevention and intervention

A Walker, Y Kim, J Blair Price, R Kale, J McGillivray, M Berk, S Tye

(2014), Vol. 5, Frontiers in Psychiatry, C1-1

journal article
2013

Chronic adrenocorticotrophic hormone treatment alters tricyclic antidepressant efficacy and prefrontal monoamine tissue levels

A Walker, S Burnett, K Hasebe, J McGillivray, L Gray, S McGee, K Walder, M Berk, S Tye

(2013), Vol. 242, pp. 76-83, Behavioural Brain Research, C1

journal article

Funded Projects at Deakin

No Funded Projects at Deakin found

Supervisions

No completed student supervisions to report